Literature DB >> 21301793

A return to cancer metabolism.

Gregg L Semenza.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21301793     DOI： 10.1007/s00109-011-0733-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  10 in total

1.  On getting there from here.

Authors:  Steven L McKnight
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

2.  The power of the front page of The New York Times.

Authors:  E Marshall
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

Review 3.  Therapeutic targeting of cancer cell metabolism.

Authors:  Chi V Dang; Max Hamaker; Peng Sun; Anne Le; Ping Gao
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

Review 4.  Glutamine: pleiotropic roles in tumor growth and stress resistance.

Authors:  Naval P Shanware; Andrew R Mullen; Ralph J DeBerardinis; Robert T Abraham
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

Review 5.  mTOR links oncogenic signaling to tumor cell metabolism.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

6.  Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.

Authors:  Anne Le; Charles R Cooper; Arvin M Gouw; Ramani Dinavahi; Anirban Maitra; Lorraine M Deck; Robert E Royer; David L Vander Jagt; Gregg L Semenza; Chi V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

Review 7.  Causes and consequences of increased glucose metabolism of cancers.

Authors:  Robert J Gillies; Ian Robey; Robert A Gatenby
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

Review 8.  Inborn and acquired metabolic defects in cancer.

Authors:  Christian Frezza; Patrick J Pollard; Eyal Gottlieb
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 10.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867
  10 in total
  6 in total

1.  Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.

Authors:  Ubaldo E Martinez-Outschoorn; Richard G Pestell; Anthony Howell; Mark L Tykocinski; Fnu Nagajyothi; Fabiana S Machado; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

Review 2.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

Review 3.  Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes.

Authors:  Federico Andreoli; Alberto Del Rio
Journal:  Comput Struct Biotechnol J       Date:  2015-05-07       Impact factor: 7.271

4.  Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy.

Authors:  Hao Geng; Changhui Xue; Janet Mendonca; Xiao-Xin Sun; Qiong Liu; Patrick N Reardon; Yingxiao Chen; Kendrick Qian; Vivian Hua; Alice Chen; Freddy Pan; Julia Yuan; Sang Dang; Tomasz M Beer; Mu-Shui Dai; Sushant K Kachhap; David Z Qian
Journal:  Nat Commun       Date:  2018-11-26       Impact factor: 14.919

5.  The emerging role of fumarate as an oncometabolite.

Authors:  Ming Yang; Tomoyoshi Soga; Patrick J Pollard; Julie Adam
Journal:  Front Oncol       Date:  2012-07-31       Impact factor: 6.244

6.  Did we get pasteur, warburg, and crabtree on a right note?

Authors:  Lakshmipathi Vadlakonda; Abhinandita Dash; Mukesh Pasupuleti; Kotha Anil Kumar; Pallu Reddanna
Journal:  Front Oncol       Date:  2013-07-15       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.